FDA approves subcutaneous isatuximab-irfc for multiple myeloma indications, offering an efficient delivery alternative to intravenous administration. The US Food and Drug Administration (FDA) has ...
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...
One of South Carolina’s top providers of MSC injections opens a new clinic to offer services to more patients in the area. MOUNT PLEASANT, SC, UNITED STATES, June ...
Subcutaneous anifrolumab 120mg weekly demonstrated a statistically significant and clinically meaningful reduction in SLE disease activity (58.5% BICLA response vs 43.2% for placebo) with a safety ...
Credit: AstraZeneca. The new weekly 120 mg SC formulation, supported by TULIP-SC trial results, offers patients with moderate to severe SLE a self-administered alternative to monthly IV infusions.
About a decade ago, a group of competitive CrossFitters in Charleston, South Carolina, went looking for ways to improve their athletic performance without taking steroids. At the time, members of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results